118 related articles for article (PubMed ID: 7986267)
1. WH14, a marker of precursor-B leukemia/lymphoma is available for paraffin-embedded section.
Nakamura N; Honta Y; Abe M; Sakuma H; Wakasa H
Eur J Haematol; 1994 Jul; 53(1):49-50. PubMed ID: 7986267
[No Abstract] [Full Text] [Related]
2. A novel monoclonal antibody specific for human pre-B cell leukemia/lymphoma.
Nakamura N; Morimura Y; Abe M; Wakasa H
Eur J Haematol; 1991 Sep; 47(3):168-73. PubMed ID: 1915799
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of myeloid-associated antigen expression on blast cells in children with acute lymphoblastic leukemia. The Austrian Pediatric Oncology Group.
Fink FM; Köller U; Mayer H; Haas OA; Grümayer-Panzer ER; Urban C; Dengg K; Mutz I; Tüchler H; Gatterer-Menz I
Med Pediatr Oncol; 1993; 21(5):340-6. PubMed ID: 8492748
[TBL] [Abstract][Full Text] [Related]
4. Detection of intracellular/intranuclear antigens. Applications in leukemia/lymphoma analysis.
Widen RH
Methods Mol Biol; 1998; 91():47-55. PubMed ID: 9664480
[No Abstract] [Full Text] [Related]
5. CD10/common acute lymphoblastic leukemia-associated antigen and adhesion factor expression is predictive for lymphokine-activated killing sensitivity of adult B-lineage acute lymphoblastic leukemia.
Correale P; Tagliaferri P; Camera A; Caraglia M; Del Vecchio L; De Laurentis M; Pinto A; Rotoli B; Bianco AR
Year Immunol; 1993; 7():90-5. PubMed ID: 7690510
[No Abstract] [Full Text] [Related]
6. Biochemical and immunologic diagnosis of cancer. Leukemia and lymphoma.
Shiku H
Tumour Biol; 1987; 8(2-3):156-60. PubMed ID: 3329399
[No Abstract] [Full Text] [Related]
7. [Use of monoclonal antibodies in acute lymphoblastic leukemia in children. I. Immunological subclassification of acute lymphoblastic leukemia].
Kołecki P; Radwańska U
Pediatr Pol; 1988 Nov; 63(11):693-7. PubMed ID: 3253655
[No Abstract] [Full Text] [Related]
8. Antibody NCL-CD5 fails to detect neoplastic CD5+ cells in paraffin sections.
Ben-Ezra JM; Kornstein MJ
Am J Clin Pathol; 1996 Sep; 106(3):370-3. PubMed ID: 8816596
[TBL] [Abstract][Full Text] [Related]
9. The value of anti-pax-5 immunostaining in routinely fixed and paraffin-embedded sections: a novel pan pre-B and B-cell marker.
Torlakovic E; Torlakovic G; Nguyen PL; Brunning RD; Delabie J
Am J Surg Pathol; 2002 Oct; 26(10):1343-50. PubMed ID: 12360049
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotyping of lymphomas and leukemias in paraffin-embedded tissues.
Perkins SL; Kjeldsberg CR
Am J Clin Pathol; 1993 Apr; 99(4):362-73. PubMed ID: 8475901
[No Abstract] [Full Text] [Related]
11. Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement.
Lin P; Jones D; Dorfman DM; Medeiros LJ
Am J Surg Pathol; 2000 Nov; 24(11):1480-90. PubMed ID: 11075849
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of a new marker for common acute lymphoblastic leukemia detected by two-dimensional electrophoresis.
Hanash SM; Kuick R; Nichols D; Stoolman L
Dis Markers; 1988; 6(4):209-20. PubMed ID: 2976630
[TBL] [Abstract][Full Text] [Related]
13. Lymphoma phenotyping in formalin-fixed and paraffin wax-embedded tissues. I. Range of antibodies and staining patterns.
Norton AJ; Isaacson PG
Histopathology; 1989 May; 14(5):437-46. PubMed ID: 2661395
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies marking B-cell non-Hodgkin's lymphoma in paraffin-embedded tissue.
Linder J; Ye Y; Armitage JO; Weisenburger DD
Mod Pathol; 1988 Jan; 1(1):29-34. PubMed ID: 3266335
[TBL] [Abstract][Full Text] [Related]
15. CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment.
Mejstríková E; Hrusak O; Borowitz MJ; Whitlock JA; Brethon B; Trippett TM; Zugmaier G; Gore L; von Stackelberg A; Locatelli F
Blood Cancer J; 2017 Dec; 7(12):659. PubMed ID: 29259173
[No Abstract] [Full Text] [Related]
16. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
Epstein AL; Marder RJ; Winter JN; Fox RI
J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
[TBL] [Abstract][Full Text] [Related]
17. Paraffin immunohistochemistry as an adjunct to hematopathology.
Abbondanzo SL
Ann Diagn Pathol; 1999 Oct; 3(5):318-27. PubMed ID: 10556481
[TBL] [Abstract][Full Text] [Related]
18. MIC2, TdT, bcl-2, and CD34 expression in paraffin-embedded high-grade lymphoma/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities.
Soslow RA; Bhargava V; Warnke RA
Hum Pathol; 1997 Oct; 28(10):1158-65. PubMed ID: 9343323
[TBL] [Abstract][Full Text] [Related]
19. Complement-dependent cytotoxicity induced by therapeutic antibodies in B-cell acute lymphoblastic leukemia is dictated by target antigen expression levels and augmented by loss of membrane-bound complement inhibitors.
Loeff FC; van Egmond HME; Nijmeijer BA; Falkenburg JHF; Halkes CJ; Jedema I
Leuk Lymphoma; 2017 Sep; 58(9):1-14. PubMed ID: 28140725
[TBL] [Abstract][Full Text] [Related]
20. Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma.
Pilozzi E; Pulford K; Jones M; Müller-Hermelink HK; Falini B; Ralfkiaer E; Pileri S; Pezzella F; De Wolf-Peeters C; Arber D; Stein H; Mason D; Gatter K
J Pathol; 1998 Oct; 186(2):140-3. PubMed ID: 9924428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
